ReviewJournal of clinical medicine2021

Update on TDM (Therapeutic Drug Monitoring) with Ustekinumab, Vedolizumab and Tofacitinib in Inflammatory Bowel Disease.

Sophie Restellini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.